NCT04908748View on ClinicalTrials.gov

Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

November 9, 2021

Study Completion Date

December 15, 2021

Conditions
Soft Tissue InjuriesContusionsStrainsSprainsBruises
Interventions
DRUG

Esflurbiprofen Hydrogel Patch

Esflurbiprofen is a cyclooxygenase (COX) inhibitor

Trial Locations (1)

50933

Deutsche Sporthochschule Köln Institut für Kreislaufforschung und Sportmedizin, Cologne

Sponsors

Collaborators (1)

ClinSearch
All Listed Sponsors
collaborator

ClinSearch

OTHER

collaborator

CRM Biometrics GmbH

INDUSTRY

collaborator

Clinigen, Inc.

INDUSTRY

lead

Teikoku Seiyaku Co., Ltd.

INDUSTRY

NCT04908748 - Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain | Biotech Hunter | Biotech Hunter